| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/00006250-199404000-00024 |
| P698 | PubMed publication ID | 8134077 |
| P2093 | author name string | Katz VL | |
| Childress CH | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nifedipine | Q39111 |
| P304 | page(s) | 616-624 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Obstetrics and Gynecology | Q7075543 |
| P1476 | title | Nifedipine and its indications in obstetrics and gynecology | |
| P478 | volume | 83 |
| Q42050495 | A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies |
| Q46618202 | Atosiban and nifedipin for the treatment of preterm labor |
| Q34307614 | Calcium channel blockers in the management of preterm labor and hypertension in pregnancy |
| Q53887982 | Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs. |
| Q36271489 | Effect of intracellular Ca2+ chelation with the acetoxymethyl ester-derived form of bis(o-aminophenoxy)ethane-N,N,N,N',N'-tetraacetic acid on meiotic division and chromosomal segregation in mouse oocytes |
| Q73285170 | Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe |
| Q42269581 | Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia |
| Q50196685 | Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy-induced severe pre-eclampsia: A double-blind, randomized and placebo-controlled clinical study |
| Q48955265 | Evidence-based labour ward guidelines for the diagnosis, management and treatment of spontaneous preterm labour |
| Q77470355 | Human fetal membranes release a Ca++ channel inhibitor |
| Q37055929 | Ischaemic heart disease in pregnancy |
| Q43871067 | Long-term treatment with nicardipine for severe pre-eclampsia |
| Q43953626 | Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia |
| Q36044512 | Nifedipine trials: effectiveness and safety aspects |
| Q73069288 | Obstetric complications and rheumatic disease |
| Q73069275 | Obstetric management of the high-risk lupus pregnancy |
| Q51427170 | Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. |
| Q51749129 | Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. |
| Q74245805 | Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states |
| Q53735908 | The Effects of Platelet-Activating Factor on Uterine Contractility, Perfusion, Hypoxia, and Pain in Mice. |
| Q47103299 | Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial |
| Q79788829 | [ST segment elevation acute coronary syndrome during pregnancy: a case report and review of therapeutic options] |
Search more.